Ligand validation:2EI4

RET: RETINAL

RET is a Ligand Of Interest in 2EI4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2EI4_RET_A_260	85%	5%	0.101	0.966	3.33	2.11	9	15	1	0	100%	0.9524
3WQJ_RET_A_301	72%	9%	0.117	0.941	1.13	3.32	1	13	2	0	100%	0.9524
1VGO_RET_B_261	64%	7%	0.167	0.968	3.32	1.64	5	8	2	0	100%	0.9524
2Z55_RET_A_260	60%	5%	0.155	0.942	3.19	2.11	7	14	2	0	100%	0.9524
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	0.9524
3UTX_RET_B_301	100%	6%	0.042	0.988	2.42	2.7	5	12	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
7XJC_RET_A_301	97%	10%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752
7XJD_RET_A_301	97%	10%	0.06	0.972	1.93	2.42	2	14	0	0	100%	0.9524

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.